Hims & Hers Health (HIMS) Change in Accured Expenses (2019 - 2026)
Hims & Hers Health's (HIMS) quarterly Change in Accured Expenses came in at $10.0 million in Q1 2026, up 130.2% year-on-year from $4.4 million in Q1 2025, and up 625.22% quarter-over-quarter from -$1.9 million in Q4 2025.
Hims & Hers Health (HIMS) Change in Accured Expenses (2019 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Change in Accured Expenses across 8 years of filings, most recently posting $10.0 million for Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at $10.0 million, up 130.2% year-over-year; the trailing twelve-month figure through Mar 2026 was -$37.4 million (down 222.99% YoY), and the FY2025 annual result was -$43.1 million, down 280.96% from the prior year.
- Change in Accured Expenses came in at $10.0 million for Q1 2026 at Hims & Hers Health, up from -$1.9 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $14.0 million in Q3 2024 to a low of -$52.9 million in Q3 2025.
- The 5-year median for Change in Accured Expenses is $3.3 million (2022), against an average of $481588.2.
- Across the five-year window, Change in Accured Expenses plunged 565.29% in 2022 and soared 507.26% in 2024, its largest moves.
- Hims & Hers Health's Change in Accured Expenses stood at -$4.6 million in 2022, then soared by 134.96% to $1.6 million in 2023, then jumped by 507.26% to $9.8 million in 2024, then sank by 119.48% to -$1.9 million in 2025, then soared by 625.22% to $10.0 million in 2026.
- The last three Change in Accured Expenses figures came in at $10.0 million (Q1 2026), -$1.9 million (Q4 2025), and -$52.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 23.00 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 10.02 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 14.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.02 Mn |
| Mar 31, 2026 | 10.02 Mn |
| Dec 31, 2025 | -1.91 Mn |
| Dec 31, 2025 | -1.91 Mn |
| Sep 30, 2025 | -52.88 Mn |
| Sep 30, 2025 | -52.88 Mn |
| Jun 30, 2025 | 7.39 Mn |
| Jun 30, 2025 | 7.39 Mn |
| Mar 31, 2025 | 4.35 Mn |
| Mar 31, 2025 | 4.35 Mn |
| Dec 31, 2024 | 9.79 Mn |
| Dec 31, 2024 | 9.79 Mn |
| Sep 30, 2024 | 14.03 Mn |
| Sep 30, 2024 | 14.03 Mn |
| Jun 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | 2.23 Mn |
| Mar 31, 2024 | -2.26 Mn |
| Mar 31, 2024 | -2.26 Mn |
| Dec 31, 2023 | 1.61 Mn |
| Dec 31, 2023 | 1.61 Mn |